开发用于预测皮下注射单克隆抗体和寡核苷酸生物利用度的体外生物药剂学工具

IF 5 2区医学 Q1 PHARMACOLOGY & PHARMACY

Expert Opinion on Drug Delivery Pub Date : 2024-09-16 DOI:10.1080/17425247.2024.2403469

Karin Somby, Valerio Campagna, Manuel V. Sanchez-Felix, Ben Forbes, Driton Vllasaliu

引用次数: 0

摘要

发表于《给药专家意见》（刚刚接受，2024 年）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Development of in vitro biopharmaceutics tools for predicting the bioavailability of subcutaneously injected monoclonal antibodies and oligonucleotides

Published in Expert Opinion on Drug Delivery (Just accepted, 2024)

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Expert Opinion on Drug Delivery 医学-药学

CiteScore

11.10

自引率

3.00%

发文量

104

审稿时长

3 months

期刊介绍： Expert Opinion on Drug Delivery (ISSN 1742-5247 [print], 1744-7593 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles covering all aspects of drug delivery research, from initial concept to potential therapeutic application and final relevance in clinical use. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.